Revenue
2017
2018
2019
2020
2021
2022
2023
2024
2025
Twist Bioscience Corp (TWST)
Price$124.72Cached quote
Net income
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $376.6M | $313.0M | $245.1M | $203.6M | $132.3M | $90.1M | $54.4M | $25.4M | $10.8M |
| Gross profit | $191.0M | $133.3M | $89.7M | $84.2M | $51.7M | $28.7M | $7.0M | −$6.8M | −$13.3M |
| Gross margin | 50.72% | 42.61% | 36.61% | 41.38% | 39.08% | 31.85% | 12.80% | −26.59% | −123.09% |
| Research & development | $80.3M | $90.9M | $106.9M | $120.3M | $69.1M | $43.0M | $35.7M | $20.3M | $19.2M |
| Operating expenses | $512.8M | $533.8M | $462.3M | $438.3M | $285.1M | $230.2M | $163.2M | $96.0M | $69.2M |
| Operating income | −$136.3M | −$220.8M | −$217.2M | −$234.8M | −$152.7M | −$140.1M | −$108.8M | −$70.6M | −$58.5M |
| Operating margin | −36.18% | −70.56% | −88.60% | −115.33% | −115.41% | −155.47% | −200.15% | −277.50% | −543.16% |
| EBITDA | −$111.4M | −$189.4M | −$187.8M | −$218.3M | −$143.0M | −$133.4M | −$102.7M | −$64.8M | −$53.5M |
| EBITDA margin | −29.58% | −60.52% | −76.64% | −107.22% | −108.04% | −148.06% | −188.91% | −254.97% | −496.53% |
| Net income | −$77.7M | −$208.7M | −$204.6M | −$217.9M | −$152.1M | −$139.9M | −$107.7M | −$71.2M | −$59.3M |
| Net profit margin | −20.63% | −66.69% | −83.48% | −107.02% | −114.94% | −155.31% | −197.98% | −280.16% | −550.85% |
| Basic EPSper basic share | -$1.30 | -$3.60 | -$3.60 | -$4.04 | -$3.15 | -$3.57 | -$3.92 | -$25.51 | -$0.02 |
| Diluted EPSper diluted share | -$1.30 | -$3.60 | -$3.60 | -$4.04 | -$3.15 | -$3.57 | -$3.92 | -$25.51 | -$0.02 |
Owners
Reported shareholders
9.31%of listed shares
BlackRock, Inc.5.83M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
BlackRock, Inc. | 9.31%5.83M shares |
Artisan Partners Limited Partnership | 7.66%4.8M shares |
FMR LLC | 7.50%4.7M shares |
ARK Investment Management LLC | 7.26%4.55M shares |
PRICE T ROWE ASSOCIATES INC /MD/ | 5.80%3.63M shares |
STATE STREET CORP | 5.16%3.23M shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | 4.51%2.82M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 4.31%2.7M shares |
EdgePoint Investment Group Inc. | 4.02%2.52M shares |
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 3.47%2.17M shares |
FARALLON CAPITAL MANAGEMENT, L.L.C. | 3.41%2.14M shares |
Invesco Ltd. | 3.08%1.93M shares |
GEODE CAPITAL MANAGEMENT, LLC | 2.58%1.62M shares |
Thrivent Financial for Lutherans | 2.29%1.43M shares |
GOLDMAN SACHS GROUP INC | 2.25%1.41M shares |
MORGAN STANLEY | 1.90%1.19M shares |
D. E. Shaw & Co., Inc. | 1.89%1.19M shares |
BAILLIE GIFFORD & CO | 1.73%1.09M shares |
Driehaus Capital Management LLC | 1.63%1.02M shares |
Sumitomo Mitsui Trust Group, Inc. | 1.60%1M shares |
Percentages use 62.67M shares of this listed class outstanding on Jun 30, 2026.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 25, 2026Form 4 · 10b5-1 | Leproust Emily M.Chief Executive Officer | SellCommon Stock | 18.9K | $95.00 | $1.79M | 824.0K |
| Jun 24, 2026Form 4 · 10b5-1 | Cho DennisSee Remarks | SellCommon Stock | 14.2K | $89.75 | $1.27M | 105.1K |
| Jun 22, 2026Form 4 | Green PaulaSVP of Human Resources | SellCommon Stock | 291 | $87.32 | $25.4K | 120.4K |
| Jun 22, 2026Form 4 | Cho DennisSee Remarks | SellCommon Stock | 346 | $87.32 | $30.2K | 119.3K |
| Jun 22, 2026Form 4 | Leproust Emily M.Chief Executive Officer | SellCommon Stock | 1.7K | $87.32 | $147.4K | 842.9K |